e-learning
resources
Berlin 2008
Monday, 06.10.2008
Various aspects of thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relation between bone metastasis in lung cancer and serum IL-6 levels
D. Yilmaz Kaymaz, B. Akkalyoncu, F. Ugurman, U. Onde, B. Samurkasoglu, A. Gozu, G. Onde Ucoluk (Ankara, Turkey)
Source:
Annual Congress 2008 - Various aspects of thoracic oncology
Session:
Various aspects of thoracic oncology
Session type:
Thematic Poster Session
Number:
2658
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Yilmaz Kaymaz, B. Akkalyoncu, F. Ugurman, U. Onde, B. Samurkasoglu, A. Gozu, G. Onde Ucoluk (Ankara, Turkey). Relation between bone metastasis in lung cancer and serum IL-6 levels. Eur Respir J 2008; 32: Suppl. 52, 2658
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Increased serum levels of IL-18 are associated with lower survival and bone metastasis in non-small-cell lung cancer
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Serum tumor markers in lung cancer patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Evaluation of serum tumour markers in the lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002
Serum levels of interleukin 8 and plasma levels of osteopontin in patients with non-small cell lung cancer during chemotherapy
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Clinical significance of serum osteopontin levels in lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Serum levels of STR-3 and TIMP-2 in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 230s
Year: 2002
Clinical significance of serum adipokines levels in lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
The correlation of serum tumor markers and distant metastasis in lung adenocarcinoma
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Evaluation of serum levels of Sirtuin-1 in lung cancer patients
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Late Breaking Abstract - Decreased thrombospondin-1 and bone morphogenetic protein-4 serum levels in non-small-cell lung cancer and the relationship of these proteins with the stage of the disease.
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Prognostic value of il-6 and TNF-alfa serum concentration in advanced non-small lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 251s
Year: 2003
Elevation of serum tumor markers in patients with interstitial lung disease
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Serum levels of sFas and sFasL during chemotherapy of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 329s
Year: 2005
Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
Usefulness of bone metabolic markers in the bone metastasis from lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002
Serum level of interleukin-6 as a prognostic factor in advanced nonsmall-cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 250s
Year: 2003
CEA levels in the serum and induced sputum of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005
A serum level of IGF-I and IGFBP-3 in patients with lung cancer during chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 329s
Year: 2005
Serum hepcidin and iron are associated with non-small cell lung cancer stage
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept